These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 10760205)

  • 21. Improved Prediction of CD34+ Cell Yield before Peripheral Blood Hematopoietic Progenitor Cell Collection Using a Modified Target Value-Tailored Approach.
    Sheppard D; Tay J; Palmer D; Xenocostas A; Doulaverakis C; Huebsch L; McDiarmid S; Tinmouth A; Mallick R; Martin L; Birch P; Hamelin L; Allan D; Bredeson C
    Biol Blood Marrow Transplant; 2016 Apr; 22(4):763-767. PubMed ID: 26643030
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Single leukapheresis products collected from healthy donors after the administration of granulocyte colony-stimulating factor contain ten-fold higher numbers of long-term reconstituting hematopoietic progenitor cells than conventional bone marrow allografts.
    Theilgaard-Mönch K; Raaschou-Jensen K; Andersen H; Russell CA; Vindeløv L; Jacobsen N; Dickmeiss E
    Bone Marrow Transplant; 1999 Feb; 23(3):243-9. PubMed ID: 10084255
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Blast counts in blood progenitor cell (BPC) correlate with CD34+ cells and CFU-GM and are useful predictor of haemopoietic recovery after autologous BPC transplantation collections.
    Mijovic A; Fishlock K; Pagliuca A; Mufti GJ
    Bone Marrow Transplant; 1998 May; 21(9):869-72. PubMed ID: 9613777
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biological characterization of CD34+ cells mobilized into peripheral blood.
    Lemoli RM; Tafuri A; Fortuna A; Catani L; Rondelli D; Ratta M; Tura S
    Bone Marrow Transplant; 1998 Dec; 22 Suppl 5():S47-50. PubMed ID: 9989890
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Peripheral blood progenitor cell collections in cancer patients: analysis of factors affecting the yields.
    Sautois B; Fraipont V; Baudoux E; Fassotte MF; Hermanne JP; Jérusalem G; Bours V; Bosquée L; Schaaf-Lafontaine N; Paulus JM; Sondag D; Fillet G; Beguin Y
    Haematologica; 1999 Apr; 84(4):342-9. PubMed ID: 10190949
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enumeration of CD34+ hematopoietic progenitor cells in peripheral blood and leukapheresis products by microvolume fluorimetry: a comparison with flow cytometry.
    Read EJ; Kunitake ST; Carter CS; Chau Q; Yu MY; Klein HG
    J Hematother; 1997 Aug; 6(4):291-301. PubMed ID: 9377067
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of ISHAGE protocol CD34 cell enumeration with a lineage negative backgating technique.
    Pirruccello SJ; Page CJ; Bishop MR; Letheby BA; Warkentin PI; Jackson JD; Kessinger A
    Cytotherapy; 1999; 1(4):279-86. PubMed ID: 20426553
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Flow cytometric enumeration of CD34+ hematopoietic stem and progenitor cells. European Working Group on Clinical Cell Analysis.
    Gratama JW; Orfao A; Barnett D; Brando B; Huber A; Janossy G; Johnsen HE; Keeney M; Marti GE; Preijers F; Rothe G; Serke S; Sutherland DR; Van der Schoot CE; Schmitz G; Papa S
    Cytometry; 1998 Jun; 34(3):128-42. PubMed ID: 9696157
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multicenter study to evaluate a new enumeration method for hematopoietic stem cell collection management.
    Grommé M; Russcher H; Braakman E; Klinkspoor JH; Dobber JA; de Greef I; de Wit NCJ
    Transfusion; 2017 Aug; 57(8):1949-1955. PubMed ID: 28653370
    [TBL] [Abstract][Full Text] [Related]  

  • 30. External quality assurance for CD34 cell enumeration--results of a preliminary national trial. Royal Microscopical Society Clinical Flow Cytometry Group QA Schemes.
    Lowdell MW; Bainbridge DR
    Bone Marrow Transplant; 1996 May; 17(5):849-53. PubMed ID: 8733708
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Delayed effects of rhG-CSF mobilization treatment and apheresis on circulating CD34+ and CD34+ Thy-1dim CD38- progenitor cells, and lymphoid subsets in normal stem cell donors for allogeneic transplantation.
    Körbling M; Anderlini P; Durett A; Maadani F; Bojko P; Seong D; Giralt S; Khouri I; Andersson B; Mehra R; vanBesien K; Mirza N; Przepiorka D; Champlin R
    Bone Marrow Transplant; 1996 Dec; 18(6):1073-9. PubMed ID: 8971375
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pluripotent and myeloid-committed CD34+ subsets in hematopoietic stem cell allografts.
    Theilgaard-Mönch K; Raaschou-Jensen K; Schjødt K; Heilmann C; Vindeløv L; Jacobsen N; Dickmeiss E
    Bone Marrow Transplant; 2003 Dec; 32(12):1125-33. PubMed ID: 14647266
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of stem cell apheresis products using intermediate-dose filgrastim plus large volume apheresis for allogeneic transplantation.
    Engelhardt M; Bertz H; Wäsch R; Finke J
    Ann Hematol; 2001 Apr; 80(4):201-8. PubMed ID: 11401085
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential kinetics of primitive hematopoietic cells assayed in vitro and in vivo during serum-free suspension culture of CD34+ blood progenitor cells.
    Möbest D; Goan SR; Junghahn I; Winkler J; Fichtner I; Hermann M; Becker M; de Lima-Hahn E; Henschler R
    Stem Cells; 1999; 17(3):152-61. PubMed ID: 10342558
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Standardization of the CFU-GM assay: Advantages of plating a fixed number of CD34+ cells in collagen gels.
    Dobo I; Pineau D; Robillard N; Geneviève F; Piard N; Zandecki M; Hermouet S
    J Hematother Stem Cell Res; 2003 Oct; 12(5):543-51. PubMed ID: 14594511
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel and rapid enumeration method of peripheral blood stem cells using automated hematology analyzer.
    Tanosaki R; Kumazawa T; Yoshida A; Oguni S; Nakano A; Yamagata S; Takahashi N; Kurosawa S; Kim SW; Yamashita T; Mori S; Heike Y; Fukuda T; Hamaguchi Y; Tsuda H
    Int J Lab Hematol; 2014 Oct; 36(5):521-30. PubMed ID: 24373185
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Circulating CD34+ cell counts as predictive parameter for the efficacy of peripheral stem cell apheresis in Ewing tumor patients.
    Engel BC; Laws HJ; Dirksen U; Kramm CM; Göbel U; Burdach SE
    Klin Padiatr; 1997; 209(4):186-90. PubMed ID: 9293449
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Kinetics of peripheral blood stem cell collection in large-volume leukapheresis for pediatric patients undergoing chemotherapy and adult patients before chemotherapy.
    Yamaguchi E; Yamato K; Miyata Y
    J Hematother Stem Cell Res; 2000 Aug; 9(4):565-72. PubMed ID: 10982257
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increasing the economic efficacy of peripheral blood progenitor cell collections by monitoring peripheral blood CD34+ concentrations.
    Gutensohn K; Magens MM; Kuehnl P; Zeller W
    Transfusion; 2010 Mar; 50(3):656-62. PubMed ID: 20042030
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enumeration of CD34-positive hematopoietic progenitor cells by flow cytometry: comparison of a volumetric assay and the ISHAGE gating strategy.
    Leuner S; Arland M; Kahl C; Jentsch-Ullrich K; Franke A; Höffkes HG
    Bone Marrow Transplant; 1998 Oct; 22(7):699-706. PubMed ID: 9818700
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.